NASDAQ:ATHA
Athira Pharma, Inc. Stock News
$2.52
-0.190 (-7.01%)
At Close: May 17, 2024
Radnor, Pennsylvania--(Newsfile Corp. - August 7, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") that securities fraud cl
Athira Shareholder Alert
08:39pm, Friday, 06'th Aug 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
San Francisco, California--(Newsfile Corp. - August 6, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class
Los Angeles, California--(Newsfile Corp. - August 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, I
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATHA, BZ and ATVI
05:40am, Friday, 06'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 6, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.
New Orleans, Louisiana--(Newsfile Corp. - August 5, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they hav
Athira Pharma Mourns the Loss of Chair of Board of Directors, Tadataka Yamada, M.D.
04:56pm, Thursday, 05'th Aug 2021
BOTHELL, Wash., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health a
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
11:30am, Thursday, 05'th Aug 2021
LOS ANGELES, Aug. 5, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 24, 2021 deadline to file a lead plaintiff motion in the class action filed
Los Angeles, California--(Newsfile Corp. - August 5, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, I
Athira (ATHA) to Report Q2 Earnings: What's in the Cards?
12:59pm, Wednesday, 04'th Aug 2021
Investor focus to be on the company's pipeline progress, mainly on its small molecule candidate ATH-1017 for Alzheimer's disease, on Athira's (ATHA) second-quarter earnings call.
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, DKNG and DIDI
05:40am, Wednesday, 04'th Aug 2021
NEW YORK, NY / ACCESSWIRE / August 4, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to partici
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
09:33pm, Tuesday, 03'rd Aug 2021
NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of . Athira Pharma, Inc. (" Athira " or the "Company") (NASDAQ: ATHA).
RADNOR, Pa., Aug. 3, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") investors that securities fraud class action lawsuit
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, BLCT and OTLY
03:30pm, Tuesday, 03'rd Aug 2021
NEW YORK, NY / ACCESSWIRE / August 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to partici
Los Angeles, California--(Newsfile Corp. - August 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, I
